查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2067730

美國益智藥市場規模、佔有率和趨勢分析報告：按劑型、分銷管道、主要參與者和競爭對手分析以及細分市場預測（2026-2033 年）

U.S. Nootropics Market Size, Share & Trends Analysis Report By Form (Capsules/Tablets, Powder, Drinks), By Distribution Channel (Online, Offline), Key Companies And Competitive Analysis And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國益智藥市場概況

預計到 2025 年，美國益智藥市值將達到 18.1 億美元，到 2026 年將成長至 19.8 億美元，到 2033 年將擴大至 42.6 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 11.6%。

人們對積極健康管理的興趣日益濃厚，尤其是在老年人群體中，這推動了對認知支援產品的需求。

同時，身處競爭環境的商務人士和學生都在尋求提升專注力、記憶力和專注力的方法。人們越來越接受天然草藥補充劑而非藥物，這進一步增強了以提升大腦功能為賣點的益智藥的吸引力。

益智藥產業的驅動力在於專業人士和學生對認知增強產品的需求日益成長，他們希望提高注意力、記憶力和整體認知能力。人們對與老齡化相關的認知衰退和神經退化性疾病的認知不斷提高，進一步擴大了消費群體，並支撐了各個年齡層的需求。此外，神經藥理學和生物活性成分的進步也使得開發更有效、更具針對性的配方成為可能。

該行業也受益於電子商務平台和直接面對消費者的保健品品牌的快速擴張，這顯著提高了產品的可及性和全球覆蓋範圍。同時，各公司正日益尋求策略夥伴關係和合作，以強化產品系列、利用科學專長並加速認知健康解決方案的創新。例如，2024年8月，Paradigm Sports與Ten Percent Club合作，向職業運動員和運動愛好者推廣Nootropic產品。此次合作旨在提高人們對認知增強補充劑的認知度，並擴展其在提升運動表現和注意力等方面的應用。

隨著消費者對心理健康和認知能力的關注度不斷提高，益智藥市場正蓬勃發展，因為消費者對能夠提升專注力、記憶力、情緒和整體大腦功能的產品需求日益成長。在美國，受壓力增大、遠距辦公普及以及學業壓力等因素的影響，學生、職場人士和老年人等族群對益智藥的需求不斷增加，他們希望保持思維敏捷。消費者越來越傾向於尋求有科學根據且有效的日常認知支持方案。這一趨勢為品牌創造了機遇，使其能夠提供經臨床驗證的配方，從而提升工作效率、專注力和長期大腦健康。

美國耳科藥物產業的另一個重大機會在於個人化營養和生物駭客的趨勢。消費者正在尋求針對其特定認知功能目標量身定做的解決方案，這促使企業採用可自訂的補充劑組合、針對性成分混合和訂閱模式。這些產品和服務能夠提升便利性、客戶維繫和持續收入來源。電子商務的蓬勃發展進一步加速了這一轉變，因為線上平台使產品發現、知識獲取和重複購買變得更加便捷。以訂閱主導的D2C（直接面對消費者）策略在建立長期品牌忠誠度的同時，也能降低獲客成本，因此特別有效。

給藥方式的創新也正在拓展益智藥產業的潛在市場。除了傳統的膠囊劑型，各公司還推出了軟糖、粉劑、機能飲料和即飲型飲品，以吸引注重便利性和健康意識的消費者。這些劑型有助於將益智藥融入日常生活，例如早晨提神、健身後恢復以及提高職場效率。含有蘑菇、適應原和天然興奮劑等成分的機能飲料正日益受到歡迎。

此外，與健身、健康和生活風格品牌建立合作關係，是美國市場一條極具價值的成長途徑。這些合作有助於提升品牌知名度，開拓新的零售通路，並將益智產品融入更廣泛的健康和運動表現生態系統。隨著消費者對預防性健康關注度的持續成長，產品創新、個人化客製化和生活方式融合預計將繼續成為美國益智藥產業的關鍵成長驅動力。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國益智藥市場：影響因素與趨勢

  • 市場介紹
  • 產業價值鏈分析
  • 市場動態
  • 產業分析工具
  • 打入市場策略

第4章：美國益智藥市場：消費行為分析

  • 人口統計分析
  • 消費者趨勢和偏好
  • 影響購買決策的因素
  • 消費者產品採納
  • 分析與建議

第5章：美國益智藥市場：依劑型分類的估算與趨勢分析

  • 美國益智藥市場：按劑型分類的關鍵要點
  • 特定形態波動分析、市佔率、2025 年及 2033 年
  • 市場估計與預測：依形式分類，2021-2033 年
    • 膠囊/片劑
    • 粉末
    • 飲料
    • 其他

第6章：美國益智藥市場：按分銷管道分類的估算與趨勢分析

  • 美國益智藥市場：按分銷管道分類的關鍵點
  • 分銷通路特定波動分析、市場佔有率、2025 年及 2033 年
  • 市場估計與預測：依通路分類，2021-2033年
    • 離線
    • 線上

第7章：美國益智藥市場：競爭分析

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 參與企業概況
  • 財務業績
  • 產品基準測試
  • 企業市場占有率分析，2025 年（%）
  • 企業熱力圖分析
  • 策略規劃
  • 公司簡介
    • Onnit Labs, Inc.（Uniliver）
    • Reckitt Benckiser Group PLC
    • Mind Lab Pro
    • TruBrain（TriplePulse）
    • Nooflux
    • Zhou Nutrition
    • Nootropics Depot
    • Neutonic
    • Amway Corp.
    • Natural Stacks
Product Code: GVR-4-68040-550-7

U.S. Nootropics Market Summary

The U.S. nootropics market size was valued at USD 1.81 billion in 2025 and is projected to grow from USD 1.98 billion in 2026 to USD 4.26 billion by 2033, at a CAGR of 11.6% from 2026 to 2033. Rising interest in proactive health management, particularly among aging populations, is driving demand for cognitive support products.

At the same time, professionals and students operating in competitive environments are seeking improved focus, memory, and concentration. Increasing acceptance of natural and herbal supplements over pharmaceuticals is further enhancing the appeal of nootropics marketed as brain-boosting solutions.

The nootropics industry is driven by rising demand for cognitive enhancement products among professionals and students seeking better focus, memory, and overall mental performance. Growing awareness of age-related cognitive decline and neurodegenerative conditions has further broadened the consumer base, supporting demand across wider age groups. In addition, advancements in neuropharmacology and bioactive ingredients are enabling the development of more effective and targeted formulations.

The industry is also benefiting from the rapid expansion of e-commerce platforms and direct to consumer supplement brands, which have significantly improved product accessibility and global reach. At the same time, companies are increasingly entering strategic partnerships and collaborations to strengthen product portfolios, leverage scientific expertise, and accelerate innovation in cognitive wellness solutions. For example, in August 2024, Paradigm Sports partnered with Ten Percent Club to promote nootropics among professional athletes and sports enthusiasts. The partnership focuses on increasing awareness of cognitive-enhancing supplements and expanding adoption in sports performance and mental focus applications.

The nootropics market is gaining strong momentum as rising consumer awareness of mental health and cognitive wellness increases demand for products that support focus, memory, mood, and overall brain performance. In the U.S. nootropics industry, growing stress levels, remote work lifestyles, and academic pressure are expanding adoption across students, working professionals, and older adults seeking to maintain mental sharpness. Consumers are increasingly looking for effective daily cognitive support solutions backed by science. This trend is creating opportunities for brands to position clinically supported formulations that address productivity, concentration, and long-term brain health.

Another major opportunity in the U.S. nootropics industry lies in personalized nutrition and biohacking trends. Consumers are seeking solutions tailored to their specific cognitive goals, encouraging companies to introduce customizable supplement stacks, targeted ingredient blends, and subscription-based models. These offerings improve convenience, customer retention, and recurring revenue streams. Strong e-commerce adoption is further accelerating this shift, as online platforms make product discovery, education, and repeat purchases easier. Subscription-led direct-to-consumer strategies are particularly effective in building long-term brand loyalty while lowering customer acquisition costs.

Innovation in delivery formats is also expanding the addressable market within the nootropics industry. Beyond traditional capsules, companies are launching gummies, powders, functional beverages, and ready-to-drink shots to appeal to convenience-focused and wellness-oriented consumers. These formats help integrate nootropics into daily routines such as morning energy rituals, fitness recovery, and workplace productivity habits. Functional beverages infused with ingredients such as mushrooms, adaptogens, and natural stimulants are gaining notable traction.

In addition, partnerships with fitness, wellness, and lifestyle brands present a valuable growth avenue for the U.S. market. Collaborations can improve brand visibility, create new retail channels, and position nootropic products as part of broader health and performance ecosystems. As consumer interest in preventive wellness continues to rise, product innovation, personalization, and lifestyle integration are expected to remain key growth drivers for the U.S. nootropics industry.

U.S. Nootropics Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. nootropics market report based on the form, and distribution channel.

  • Form Outlook (Revenue, USD Billion, 2021 - 2033)
  • Capsules/Tablets
  • Powder
  • Drinks
  • Others
  • Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Offline
  • Online

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Materials & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Form Outlook
  • 2.3. Distribution Channel Outlook
  • 2.4. Competitive Landscape Snapshot

Chapter 3. U.S. Nootropics Market Variables and Trends

  • 3.1. Market Introduction
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Raw Material Trends & Outlook
    • 3.2.2. Retail/Sales Channel Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. U.S. Nootropics Market: Consumer Behavior Analysis

  • 4.1. Demographic Analysis
  • 4.2. Consumer Trends & Preferences
  • 4.3. Factors Affecting Buying Decisions
  • 4.4. Consumer Product Adoption
  • 4.5. Observations & Recommendations

Chapter 5. U.S. Nootropics Market: Form Estimates & Trend Analysis

  • 5.1. U.S. Nootropics Market, By Form: Key Takeaways
  • 5.2. Form Movement Analysis & Market Share, 2025 & 2033
  • 5.3. Market Estimates & Forecasts by Form, 2021 - 2033 (USD Billion)
    • 5.3.1. Capsules/Tablets
      • 5.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.2. Powder
      • 5.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.3. Drinks
      • 5.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 5.3.4. Other
      • 5.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 6. U.S. Nootropics Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. U.S. Nootropics Market, By Distribution Channel: Key Takeaways
  • 6.2. Distribution Channel Movement Analysis & Market Share, 2025 & 2033
  • 6.3. Market Estimates & Forecasts by Distribution Channel, 2021 - 2033 (USD Billion)
    • 6.3.1. Offline
      • 6.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
    • 6.3.2. Online
      • 6.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)

Chapter 7. U.S. Nootropics Market: Competitive Analysis

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Participant's Overview
  • 7.4. Financial Performance
  • 7.5. Product Benchmarking
  • 7.6. Company Market Share Analysis, 2025 (%)
  • 7.7. Company Heat Map Analysis
  • 7.8. Strategy Mapping
  • 7.9. Company Profiles
    • 7.9.1. Onnit Labs, Inc. (Uniliver)
      • 7.9.1.1. Company Overview
      • 7.9.1.2. Financial Performance
      • 7.9.1.3. Product Portfolios
      • 7.9.1.4. Strategic Initiatives
    • 7.9.2. Reckitt Benckiser Group PLC
      • 7.9.2.1. Company Overview
      • 7.9.2.2. Financial Performance
      • 7.9.2.3. Product Portfolios
      • 7.9.2.4. Strategic Initiatives
    • 7.9.3. Mind Lab Pro
      • 7.9.3.1. Company Overview
      • 7.9.3.2. Financial Performance
      • 7.9.3.3. Product Portfolios
      • 7.9.3.4. Strategic Initiatives
    • 7.9.4. TruBrain (TriplePulse)
      • 7.9.4.1. Company Overview
      • 7.9.4.2. Financial Performance
      • 7.9.4.3. Product Portfolios
      • 7.9.4.4. Strategic Initiatives
    • 7.9.5. Nooflux
      • 7.9.5.1. Company Overview
      • 7.9.5.2. Financial Performance
      • 7.9.5.3. Product Portfolios
      • 7.9.5.4. Strategic Initiatives
    • 7.9.6. Zhou Nutrition
      • 7.9.6.1. Company Overview
      • 7.9.6.2. Financial Performance
      • 7.9.6.3. Product Portfolios
      • 7.9.6.4. Strategic Initiatives
    • 7.9.7. Nootropics Depot
      • 7.9.7.1. Company Overview
      • 7.9.7.2. Financial Performance
      • 7.9.7.3. Product Portfolios
      • 7.9.7.4. Strategic Initiatives
    • 7.9.8. Neutonic
      • 7.9.8.1. Company Overview
      • 7.9.8.2. Financial Performance
      • 7.9.8.3. Product Portfolios
      • 7.9.8.4. Strategic Initiatives
    • 7.9.9. Amway Corp.
      • 7.9.9.1. Company Overview
      • 7.9.9.2. Financial Performance
      • 7.9.9.3. Product Portfolios
      • 7.9.9.4. Strategic Initiatives
    • 7.9.10. Natural Stacks
      • 7.9.10.1. Company Overview
      • 7.9.10.2. Financial Performance
      • 7.9.10.3. Product Portfolios
      • 7.9.10.4. Strategic Initiatives

List of Tables

  • Table 1 U.S. Nootropics Market - Key Market Driver Analysis
  • Table 2 U.S. Nootropics Market - Key Market Restraint Analysis
  • Table 3 U.S. Nootropics Market Estimates & Forecast, By Form (USD Billion)
  • Table 4 U.S. Nootropics Market Estimates & Forecast, By Distribution Channel (USD Billion)
  • Table 5 Recent Developments & Impact Analysis, By Key Market Participants
  • Table 6 Company Market Share, 2025
  • Table 7 Company Heat Map Analysis
  • Table 8 Companies Undergoing Key Strategies

List of Figures

  • Fig. 1 US Nootropics Market Segmentation
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Research Approaches
  • Fig. 5 Primary Research Process
  • Fig. 6 Market Snapshot
  • Fig. 7 Form Snapshot
  • Fig. 8 Distribution Channel Snapshot
  • Fig. 9 Competitive Landscape Snapshot
  • Fig. 10 U.S. Nootropics Market Size (USD Billion)
  • Fig. 11 U.S. Nootropics Market Size, 2021 To 2033 (USD Billion)
  • Fig. 12 U.S. Nootropics Market: Penetration & Growth Prospect Mapping
  • Fig. 13 U.S. Nootropics Market: Value Chain Analysis
  • Fig. 14 U.S. Nootropics Market: Profit Margin Analysis
  • Fig. 15 U.S. Nootropics Market: Market Dynamics
  • Fig. 16 U.S. Nootropics Market: Porter's Five Forces Analysis
  • Fig. 17 Factors Influencing Buying Decisions for Nootropics
  • Fig. 18 U.S. Nootropics Market: Form Movement Analysis, 2025 & 2033 (%)
  • Fig. 19 U.S. Nootropics Market Estimates and Forecast, In Tablet & Capsule Form, 2021 - 2033 (USD Billion)
  • Fig. 20 U.S. Nootropics Market Estimates and Forecast, In Powdered Form, 2021 - 2033 (USD Billion)
  • Fig. 21 U.S. Nootropics Market Estimates and Forecast, In Drink Form, 2021 - 2033 (USD Billion)
  • Fig. 22 U.S. Nootropics Market Estimates and Forecast, In Other Forms 2021 - 2033 (USD Billion)
  • Fig. 23 U.S. Nootropics Market: Distribution Channel Movement Analysis, 2025 & 2033 (%)
  • Fig. 24 U.S. Nootropics Market Estimates and Forecast, Through Offline Channel, 2021 - 2033 (USD Billion)
  • Fig. 25 U.S. Nootropics Market Estimates and Forecast, Through Online Channel, 2021 - 2033 (USD Billion)
  • Fig. 26 Key Company Categorization
  • Fig. 27 Company Market Share Analysis, 2025
  • Fig. 28 Strategic Framework of the US Nootropics Market